Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ALN Implants Chirurgicaux is a French medical device company specializing in the development and manufacture of vena cava filters and retrieval systems. Established in 1992, the company focuses on providing innovative solutions for the prevention of pulmonary embolism in patients at high risk of venous thromboembolism. Its flagship product, the ALN Vena Cava Filter, is made of stainless steel and is designed for both permanent implantation and optional retrieval. The company also offers specialized extraction kits that allow for the removal of filters even after long-term implantation. ALN operates with a global reach, distributing its products to vascular surgeons and interventional radiologists worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ALN Implants Chirurgicaux.